📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A chromosomal mutation is superior to a plasmid-encoded mutation for plasmid fitness cost compensation. (2024)

First Author: Wright RCT

Attributed to: Does CRISPR-Cas immunity limit the effectiveness of phage therapy? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pbio.3002926

PubMed Identifier: 39621811

Publication URI: http://europepmc.org/abstract/MED/39621811

Type: Journal Article/Review

Volume: 22

Parent Publication: PLoS biology

Issue: 12

ISSN: 1544-9173